Legal status · Canada
Is Ginsenoside Rg3 legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Ginsenoside Rg3 can be sold in Canada as a supplement or cosmetic ingredient, classified as "Sold as a supplement". That is not drug approval: Health Canada has not evaluated any health claim, and injectable or "research use only" versions fall outside supplement rules, so that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Ginsenoside Rg3 in Canada at a glance
| Classification | Sold as a supplement |
|---|---|
| Health Canada approval status | Not a Health Canada drug approval; sold as a supplement or cosmetic |
| Human studies cited | 2 of 5 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Ginsenoside Rg3 profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
Ginsenoside Rg3 can be sold in Canada as a supplement, food or cosmetic ingredient under the classification above, without drug approval.
- 02
Supplement status means Health Canada has not evaluated any health claim; manufacturers are responsible for safety and labeling, and quality varies by product.
- 03
Injectable or "research use only" versions are not supplements. That label does not make human use lawful, and injectables fall under medicines rules.
What Ginsenoside Rg3 is
A ginseng saponin whose effect on senescence runs in both directions depending on the cell: it reversed replicative senescence in human fibroblasts in culture and is studied as a senescence inducer in tumour cells. The only human data are pharmacokinetic.
Ginsenoside Rg3 is a triterpenoid saponin from Panax ginseng, studied mainly in China and Korea. Its senescence literature is cell culture.
Mechanism: In cultured human fibroblasts, 20(S)-Rg3 restored ATP and the NAD+ to NADH ratio, downregulated PI3K and Akt through mTOR inhibition with p53 and p21 involvement, and activated sirtuin 3 and PGC1alpha to stimulate mitochondrial biogenesis; the 20(R) stereoisomer did not. In astrocyte culture, Rg3 suppressed interleukin 6 and interleukin 8 via NF-kappaB and p38 MAPK, a senomorphic action.
Regulatory history: Not approved for any indication in the United States. Sold as a ginseng-derived supplement ingredient. No senescence or ageing trial is registered.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Ginsenoside Rg3 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Ginsenoside Rg3 in other countries
United States
Not approvedSold as a dietary supplement
Is Ginsenoside Rg3 legal in the United States?United Kingdom
Not approvedSold as a supplement
Is Ginsenoside Rg3 legal in the United Kingdom?Australia
Not approvedAvailable as a supplement / complementary medicine
Is Ginsenoside Rg3 legal in Australia?Frequently asked questions
Is Ginsenoside Rg3 legal in Canada?
Ginsenoside Rg3 can be sold in Canada as a supplement or cosmetic ingredient, classified as "Sold as a supplement". That is not drug approval: Health Canada has not evaluated any health claim, and injectable or "research use only" versions fall outside supplement rules, so that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Can I buy Ginsenoside Rg3 in Canada?
Yes, in supplement or cosmetic form. In Canada Ginsenoside Rg3 is classified as "Sold as a supplement", so oral, topical or cosmetic products can be sold under supplement rules. Injectable versions and products labeled "research use only" are not supplements and are not approved for human use.
Is Ginsenoside Rg3 Health Canada approved?
No. In Canada Ginsenoside Rg3 is classified as "Sold as a supplement", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not approved for any indication in the United States. Sold as a ginseng-derived supplement ingredient. No senescence or ageing trial is registered.. On the evidence, 2 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Ginsenoside Rg3 live on its compound profile.
Ginsenoside Rg3 profileThis page is general information about the regulatory status of Ginsenoside Rg3 in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.